The Program

/ Programs & Centers / TTLF / EU Biotechnology Law & Policy News: June 2005

EU Biotechnology Law & Policy News: June 2005

Competition: European Commission fines AstraZeneca EUR 60 million for misusing patent system to delay market entry of competing generic drugs
[European Commission Press Release]

[posted @ 6/19/2005 10:48:00 AM] #

European Commission Vice-President Verheugen outlines new strategy for pharmaceutical industry
[European Commission Press Release]

[posted @ 6/12/2005 01:45:00 PM] #

New industrial strategy for the pharmaceutical sector in the EU
[European Commisssion Press Release]

[posted @ 6/12/2005 01:43:00 PM] #

European Commission Vice-President Verheugen: Future Post-G10/Pharmaceutical Strategy
[European Commission Press Release]

[posted @ 6/12/2005 01:34:00 PM] #

Mergers: European Commission clears the acquisition of Hexal by Novartis subject to conditions
[European Commission Press Release]

[posted @ 6/12/2005 01:24:00 PM] #

Biosafety: international meeting to adopt binding rules on trade in GMOs
[European Commission Press Release]

[posted @ 6/12/2005 12:56:00 PM] #

News Archives

January 2004February 2004March 2004April 2004May 2004June 2004July 2004August 2004September 2004October 2004November 2004December 2004January 2005February 2005March 2005April 2005May 2005June 2005July 2005August 2005September 2005October 2005November 2005December 2005February 2006March 2006April 2006May 2006July 2006